The consortium’s objective, which has obtained €2.5 million from the Agencia Estatal de Investigación, is to advance to the clinical phase of the antifibrinolytic agent CM-352 A public-private consortium formed by the biotechnology company Hemostatics, based in the Parc Científic de Barcelona (PCB), the Clínica Universidad de Navarra (CUN), and the Institut Català d’Investigació Química […]
Optimising the Drug Discovery phases for a more efficient pharmaceutical industry
ICIQ’s expertise and adaptability facilitate the effective identification and selection of small molecule candidates Do you need an expert team to develop a new small molecule candidate for a particular therapeutic target? Do you face challenges in any phase of your drug discovery process and need specialists to resolve them? The Drug Discovery phase is […]
Solid State characterisation: unlocking the secrets of your compounds
Crysforma offers different types of analyses to determine the properties of solid-state compounds Are you evaluating your API to select the optimal solid form? Do you need to verify any changes in the crystalline form of your API during the production and storage process? Do you want to ensure the polymorphic stability of your compound? […]
CRYSFORMA: Salt and Co-crystal screenings to get new patents and to optimize your drug substance
Do you need to optimize the chemical properties of a drug? Looking for a new patent with different substance properties? Salt and co-crystal screening studies are crucial in the development of drugs for the pharmaceutical industry. Such studies bring to companies the discovery of derivates of their drug substances with enhanced properties, which can lead […]
The experience from a leading pharma company in the ICIQ-Joint Units: “I was impressed by the level of our discussions on Medicinal Chemistry”
The Institute of Chemical Research of Catalonia (ICIQ-CERCA)-Joint Units have created a partnership agreement between companies and the centre, allowing the first ones to expand or relocate their research areas to improve their competitivity. The access to a full equipped laboratory, and to ICIQ’s Scientific Core Facilities Area, are some of the advantages of these contracts. […]
CRYSFORMA: Polymorphism and crystallization, key issues in drug development according to international health security
Are you looking for a stable polymorph of your drug substance? Do you want to avoid any manufacturability, bioavailability or clinical outcome affection during your drug development or storage due to any unknown solid form conversion? Or even do you need to demonstrate to regulation authorities your valid results? Chemical substance exists in the solid […]
CRYSFORMA, your partner in solid state development
Is your company looking for assistance or support during the drug development process? Are you filling a patent application and need additional information to protect your drug molecule? Do you need to modify your crystal properties? Have you been trying to crystallize a molecule for long time with no results? If you feel identified with some […]